NCT00728091 A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Status TERMINATED Phase PHASE3
NCT00728000 Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma Status WITHDRAWN Phase PHASE2
NCT00726674 Basal Insulin for Type 2 Diabetes Patients Treated in Outpatient Clalit Clinics Status COMPLETED Phase N/A
NCT00723216 Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery Status COMPLETED Phase PHASE3
NCT00723086 Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00721760 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery Status COMPLETED Phase PHASE3
NCT00719524 AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT00718965 Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT00718224 Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery Status COMPLETED Phase PHASE3
NCT00717938 A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00717145 Food Effects on the Relative Bioavailability of Different Dosages of Risedronate Status COMPLETED Phase PHASE1
NCT00716352 Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes Status COMPLETED Phase NA
NCT00715624 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin Status COMPLETED Phase PHASE3
NCT00714961 Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction Status COMPLETED Phase PHASE3
NCT00714597 Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility Status TERMINATED Phase PHASE3
NCT00714246 Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00713830 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea Status COMPLETED Phase PHASE3
NCT00712673 GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin Status COMPLETED Phase PHASE3